Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Codiak BioSciences revenue
Codiak BioSciences's revenue is $22.9 million.
What is Codiak BioSciences's revenue?
- Codiak BioSciences's revenue growth from 2019 to 2021 is 5,811.08%.
- Codiak BioSciences has 115 employees, and the revenue per employee ratio is $199,434.
- Codiak BioSciences's peak quarterly revenue was $13.2M in 2021(q1).
- Codiak BioSciences peak revenue was $22.9M in 2021.
- Codiak BioSciences annual revenue for 2020 was 2.9M, 651.29% growth from 2019.
- Codiak BioSciences annual revenue for 2021 was 22.9M, 686.79% growth from 2020.
On this page
Zippi applies for you, and finds you a job.
Codiak BioSciences historical revenue
Codiak BioSciences's peak revenue was $22.9M in 2021. The peak quarterly revenue was $13.2M in 2021(q1).
Codiak BioSciences's revenue increased from $388.0k in 2019 to $22.9M currently. That's a 5,811.08% change in annual revenue.
Codiak BioSciences annual revenue
Codiak BioSciences annual revenue over time
| Fiscal year / year | Codiak BioSciences revenue |
|---|---|
| 2019 | $388,000 |
| 2020 | $2.9M |
| 2021 | $22.9M |
Codiak BioSciences quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Codiak BioSciences quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | $954,000 | $1.6M |
| 2021 | $13.2M | $890,000 | $1.2M | $7.7M |
| 2022 | $12.7M | $13.1M | $522,000 | - |
Codiak BioSciences jobs nearby
Do you work at Codiak BioSciences?
Is Codiak BioSciences transparent about its revenue structure?
Codiak BioSciences financing
Codiak BioSciences received early financing of $31.0M on 2015-11-17.
| Series | Round size | Date |
|---|---|---|
| Series A | $31M | 11/2015 |
| Series B | $61M | 01/2016 |
| Series C | $76.5M | 11/2017 |
| Post Ipo Equity | $66.4M | 02/2021 |
Codiak BioSciences investors
| Investors | Security type |
|---|---|
| ARCH Venture Partners | Series A |
| Fidelity Management & Research Co LLC | Series A |
| Flagship Pioneering Inc | Series A |
| Alaska Permanent Fund | Series B |
| Alexandria Venture | Series B |
| ARCH Venture Partners | Series B |
| Yukon Partners | Series B |
| Fidelity Management & Research Co LLC | Series B |
| Flagship Pioneering Inc | Series B |
| Alaska Permanent Fund | Series C |
| EcoR1 Capital, LLC | Series C |
| Sirona Capital | Series C |
| ARCH Venture Partners | Series C |
| Yukon Partners | Series C |
| Qatar Investment Authority | Series C |
| Fidelity Management & Research Co LLC | Series C |
| Flagship Pioneering Inc | Series C |
| Boxer Capital | Series C |
| Casdin Capital | Series C |
| Alexandria Venture Investments | Series C |
Search for jobs
Codiak BioSciences highest paying jobs
Zippia gives an in-depth look into the details of Codiak BioSciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Codiak BioSciences. The employee data is based on information from people who have self-reported their past or current employments at Codiak BioSciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Codiak BioSciences. The data presented on this page does not represent the view of Codiak BioSciences and its employees or that of Zippia.
Codiak BioSciences may also be known as or be related to CODIAK BIOSCIENCES, INC., Codiak BioSciences, Codiak BioSciences, Inc., Codiak Biosciences and Codiak Biosciences, Inc.